FibroGen, Inc (FGEN) Financials

FGEN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 423.5 million 585.7 million
2023-09-30 460.4 million 575.6 million
2023-06-30 515.1 million 575.4 million
2023-03-31 538.5 million 567.4 million

FGEN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -18.6 million 9.3 million
2023-09-30 -85.2 million 9.5 million
2023-06-30 -111.6 million 15.9 million
2023-03-31 -102.2 million 16.1 million

FGEN Net Income

No data available :(

FGEN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 235.6 million - 80.6 million
2023-09-30 251.3 million - 81.9 million
2023-06-30 335.7 million 71.4 million 84.8 million
2023-03-31 355.9 million - 86.8 million

FGEN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 98.5 million
2023-09-30 98.2 million
2023-06-30 97.7 million
2023-03-31 94.7 million

FGEN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 251000 51.7 million 24.2 million -
2023-09-30 684000 61.2 million 25.6 million -
2023-06-30 993000 95.5 million 31.2 million -
2023-03-31 591000 74.5 million 34.3 million -

FGEN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 27.1 million 5.4 million
2023-09-30 40.1 million 4.2 million
2023-06-30 44.3 million 5.7 million
2023-03-31 36.2 million 3.5 million

FGEN

Price: $1.13

52 week price:
0.33
19.47

Payout Ratio Range:
-88.35%
-25.35%

Earnings Per Share: -2.92 USD

P/E Ratio: -0.89

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 1.0 million

Ebitda: -33.4 million

Market Capitalization: 136.3 million

Links: